Krzysztof Tomasiewicz

Summary

Country: Poland

Publications

  1. ncbi request reprint The risk of exposure to Anaplasma phagocytophilum infection in Mid-Eastern Poland
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Biernackiego 9, 20 089 Lublin, Poland
    Ann Agric Environ Med 11:261-4. 2004
  2. ncbi request reprint TT virus infection and pancreatic cancer: relationship or accidental coexistence
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Biernackiego 9, 20 089 Lublin, Poland
    World J Gastroenterol 11:2847-9. 2005
  3. ncbi request reprint [Impact of pegylated interferon alpha and ribavirin therapy of chronic hepatitis C on peripheral blood and intrahepatic lymphocytes]
    Krzysztof Tomasiewicz
    Uniwersytet Medyczny w Lublinie, Katedra i Klinika Chorób Zakaźnych
    Pol Merkur Lekarski 26:19-23. 2009
  4. ncbi request reprint [Intrahepatic and peripheral blood lymphocytes during hepatitis C]
    Krzysztof Tomasiewicz
    Katedra i Klinika Chor6b Zakainych Akademii Medycznej w Lublinie
    Przegl Epidemiol 60:665-72. 2006
  5. ncbi request reprint Post-exposure anti-rabies prophylaxis in Lublin province (Eastern Poland) in 2004-2005
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Biernackiego 9, 20 089 Lublin, Poland
    Ann Agric Environ Med 13:337-40. 2006
  6. ncbi request reprint Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland
    Adv Ther 23:139-42. 2006
  7. ncbi request reprint Post-exposure anti-rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2006-2011
    Joanna Krzowska-Firych
    Department of Infectious Diseases, Medical University, Lublin, Poland
    Ann Agric Environ Med 19:275-8. 2012
  8. ncbi request reprint [Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)]
    Jacek Juszczyk
    Katedra i Oddział Kliniczny Chorób Zakaźnych, SlAM, Katowice
    Przegl Epidemiol 59:651-60. 2005
  9. ncbi request reprint TT virus (TTV)--etiologic agent of acute hepatitis?
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Laboratory of Virology, Skubiszewski Medical University of Lublin
    Ann Univ Mariae Curie Sklodowska Med 59:539-42. 2004
  10. ncbi request reprint [Peginterferon alpha-2b in patients with chronic hepatitis C]
    Jacek Juszczyk
    Katedra i Klinika Chorób Zakaźnych AM w Poznaniu
    Pol Merkur Lekarski 16:353-7. 2004

Detail Information

Publications10

  1. ncbi request reprint The risk of exposure to Anaplasma phagocytophilum infection in Mid-Eastern Poland
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Biernackiego 9, 20 089 Lublin, Poland
    Ann Agric Environ Med 11:261-4. 2004
    ..phagocytophilum in the natural environment of Mid-Eastern Poland. As the risk for infection exists, it should call the attention of public health services to the possibility of an increasing number of patients with this disease...
  2. ncbi request reprint TT virus infection and pancreatic cancer: relationship or accidental coexistence
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Biernackiego 9, 20 089 Lublin, Poland
    World J Gastroenterol 11:2847-9. 2005
    ..The relationship is difficult to confirm, however the cases we present should be treated as a preliminary report and a comment on the real role of TTV in human pathology...
  3. ncbi request reprint [Impact of pegylated interferon alpha and ribavirin therapy of chronic hepatitis C on peripheral blood and intrahepatic lymphocytes]
    Krzysztof Tomasiewicz
    Uniwersytet Medyczny w Lublinie, Katedra i Klinika Chorób Zakaźnych
    Pol Merkur Lekarski 26:19-23. 2009
    ..The aim of this study was to determine the modification of T-lymphocyte subsets during pegylated interferon alpha (PegIFN) and ribavirin treatment and its correlation with response to the treatment...
  4. ncbi request reprint [Intrahepatic and peripheral blood lymphocytes during hepatitis C]
    Krzysztof Tomasiewicz
    Katedra i Klinika Chor6b Zakainych Akademii Medycznej w Lublinie
    Przegl Epidemiol 60:665-72. 2006
    ..We investigated a panel of markers of intrahepatic T-lymphocyte subsets in 44 hepatitis C virus (HCV)-infected patients...
  5. ncbi request reprint Post-exposure anti-rabies prophylaxis in Lublin province (Eastern Poland) in 2004-2005
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Biernackiego 9, 20 089 Lublin, Poland
    Ann Agric Environ Med 13:337-40. 2006
    ....
  6. ncbi request reprint Vitiligo associated with pegylated interferon and ribavirin treatment of patients with chronic hepatitis C: a case report
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Medical University of Lublin, Lublin, Poland
    Adv Ther 23:139-42. 2006
    ..The decision about whether to discontinue treatment should be discussed with the patient, who must be informed that the lesions may persist...
  7. ncbi request reprint Post-exposure anti-rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2006-2011
    Joanna Krzowska-Firych
    Department of Infectious Diseases, Medical University, Lublin, Poland
    Ann Agric Environ Med 19:275-8. 2012
    ..56% of all vaccinated patients exposed to dogs and to 20.06% exposed to cats. Rabies was confirmed mainly in domestic animals (2 cats, 1 dog). Among wild animals, only 1 case of rabies was confirmed in a single bat...
  8. ncbi request reprint [Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)]
    Jacek Juszczyk
    Katedra i Oddział Kliniczny Chorób Zakaźnych, SlAM, Katowice
    Przegl Epidemiol 59:651-60. 2005
    ..ALT levels decreased significantly during treatment in patients with and without an SVR. 38.4% of patients experienced adverse events like neutropenia, anemia, thrombocytopenia, and other. There was one death (severe thrombocytopenia)...
  9. ncbi request reprint TT virus (TTV)--etiologic agent of acute hepatitis?
    Krzysztof Tomasiewicz
    Department of Infectious Diseases, Laboratory of Virology, Skubiszewski Medical University of Lublin
    Ann Univ Mariae Curie Sklodowska Med 59:539-42. 2004
    ..The cases of acute hepatitis we present here should be treated as a preliminary report and the comment in the discussion about the real role of TTV in human pathology...
  10. ncbi request reprint [Peginterferon alpha-2b in patients with chronic hepatitis C]
    Jacek Juszczyk
    Katedra i Klinika Chorób Zakaźnych AM w Poznaniu
    Pol Merkur Lekarski 16:353-7. 2004
    ..Adverse events, which mostly were mild and were not the cause of interruption of treatment, were numerous and occurred at different frequency, in the range from over 50% (flu-like) to 0.7%...